Morgan Stanley raised the firm’s price target on Cardinal Health (CAH) to $224 from $190 and keeps an Overweight rating on the shares.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAH:
- Cardinal Health Elects Board, Approves Executive Compensation
- Cardinal Health price target raised to $210 from $170 at Mizuho
- Cardinal Health price target raised to $220 from $190 at Jefferies
- Cencora price target raised to $345 from $315 at BofA
- McKesson price target raised to $900 from $850 at BofA